Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Avaira Vitality

K-Number: K213164 · 2021-10-26

Decision Date2021-10-26
Product CodeLPL
Advisory CommitteeOP
DecisionSubstantially Equivalent

Device Summary

Avaira Vitality is a medical device manufactured by CooperVision, Inc.. It received FDA 510(k) clearance on 2021-10-26 under approval number K213164. The device is classified under product code LPL. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Avaira Vitality?

Avaira Vitality is a medical device that received FDA 510(k) clearance on 2021-10-26. It is manufactured by CooperVision, Inc.. The 510(k) number is K213164.

When was Avaira Vitality approved by the FDA?

Avaira Vitality received FDA 510(k) clearance on 2021-10-26, under approval number K213164.

What company makes Avaira Vitality?

Avaira Vitality is manufactured by CooperVision, Inc..

What is the FDA product code for Avaira Vitality?

The FDA product code for Avaira Vitality is LPL.

Other Devices by CooperVision, Inc.

View all 15 devices →

Related Devices (Code: LPL)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.